Donate
Multidrug Resistance 1 (MDR1)
Breed: Border Collie
Generic Phene Data
Breeds
Relevance Rating: There is strong evidence or research available for these breeds
Relevance Rating: There is moderate evidence or research available for these breeds
Relevance Rating: There is some evidence or research available for these breeds
Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful for these breeds
GTPs
General
Disease Name
Multidrug Resistance 1 (MDR1)
OMIA
1402
Gene Name
ABCB1
Gene Name 2
CanFam 3.1, Chr. 14
Mutation
c.296_299del4
Mutation 2
c.295_298del
Mutation 3
g.13726596_13726599del
Mutation 4
c.228_231del
Test Type
Diagnostic Tool
Details
Multi-Drug Resistance Gene, (MDR) codes for a protein that is responsible for protecting the brain by transporting potentially harmful chemicals away from the brain. In certain breeds, a mutation in the MDR1 gene causes sensitivity to Ivermectin, Loperamide, and a number of other drugs. As a result of the accumulation of toxins, the dog can show neurological symptoms including: ataxia, tremors, seizures, excessive salivation, obtundation, bradycardia, mydriasis, loss of menace, loss of papillary light responses, coma and respiratory arrest. Age of onset from birth, but symptoms only noted when exposed to drugs causing sensitivity.There are many different types of drugs that have been reported to cause problems. Some drugs include: Acepromazine, Butorphanol, Cyclosporin, Digoxin, Doxorubicin, Doramectin, Emodepside, Erythromycin, Ivermectin, Loperamide (Imodium), Milbemycin, Moxidectin, Paclitaxel, Rifampin, Selamectin, Vinblastine, Vincristine. Please note this list is not exhaustive and could be subject to change.
Details 2
Multidrug resistance 1 is caused by a lack of P-glycoprotein drug transporter in the blood-brain barrier, which is characterized by neurotoxicity after administration of certain drugs. A genetic test is available. Neurotoxicity following drug administration, which varies according to dose, is the main sign. Dogs may show ataxia, tremors, seizures, excessive salivation, obtundation, bradycardia, mydriasis, loss of menace, loss of papillary light responses, coma and respiratory arrest (Mealey et al., 2001). P-gp normally transports some chemotherapeutic agents (Vinca alkaloids, doxorubicin), immunosuppressants (cyclosporine, tacrolimus), macrocyclic lactone antiparasitic drugs (ivermectin, loperamide, milbemycin, selamectin, moxidectin), HIV-1 protease inhibitors, and steroid hormones. (From OMIA)
Patents/ Licences
Washington State University owns Patent on MDR1 genotyping: US 6790621. Wisdom Health is the only entity licensed to perform MDR1 genotyping in conjunction with breed analysis and genetic screening for multiple diseases and traits in the United States
Application Information
Published
Mealey, KL., Bentjen, SA., Gay, JM., Cantor, GH. : Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11:727-33, 2001. Pubmed reference: 11692082.
Published 2
Mizukami, K., Yabuki, A., Kohyama, M., Kushida, K., Rahman, M.M., Uddin, M.M., Sawa, M., Yamato, O. : Molecular prevalence of multiple genetic disorders in Border collies in Japan and recommendations for genetic counselling. Vet J 214:21-3, 2016. Pubmed reference: 27387721. DOI: 10.1016/j.tvjl.2016.05.004.
Published 3
Donner J, Kaukonen M, Anderson H, Moller F, Kyostila K, Sankari S, Hytonen M, Giger U, Lohi H. Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders. PLoS One. 2016 Aug 15;11(8):e0161005. [PubMed: 27525650]
Published 4
Gramer, I., Leidolf, R., Doring, B., Klintzsch, S., Kramer, EM., Yalcin, E., Petzinger, E., Geyer, J. : Breed distribution of the nt230(del4) MDR1 mutation in dogs. Vet J 189:67-71, 2011. Pubmed reference: 20655253. DOI: 10.1016/j.tvjl.2010.06.012.
Body/System/Process
Blood
Inheritance
AR
Phene Discovery
The discovery of the MDR1 mutation in dogs, establishment of genotyping procedures, development of all reagents, and research into specific problem drugs was made or conducted by Washington State University.
Breed Specific Info
Researched Breeds
Border Collie, Australian Shepherd, Collie, German Shepherd Dog, Longhaired Whippet, Miniature Australian Shepherd, Old English Sheepdog, Shetland Sheepdog, Silken Windhound, Waller, White Swiss Shepherd
HSP Test-Specific Data
PharmaDNA
INNO
Laboklin Gmbh & Co. KG
The Royal Kennel Club
Veterinary Clinical Pharmacology Laboratory (VCPL)
GTP
GTP Name
Veterinary Clinical Pharmacology Laboratory
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.296_299del4
Nature of test
mutation test
GTP Patents/ Licences/ Discovery
Washington State University owns Patent on MDR1 genotyping: US 6790621
